GlassScriptPhysician profile
Scott Brian Samera
NPI 1508145905
$2,087.34
in general payments reported to CMS, 2019-2025
11 companies · $75.49 in 2025
The $75.49 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.88 · 2020: $144 · 2021: $206 · 2022: $633 · 2023: $585 · 2024: $381 · 2025: $75.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,498.65 | 2020-2025 | Puraply, Apligraf |
| Horizon Therapeutics Plc | $242.29 | 2019-2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $154.62 | 2023-2025 | Nuzyra |
| Sunovion Pharmaceuticals INC. | $51.93 | 2020 | |
| Smith+Nephew, INC. | $31.52 | 2022-2023 | Collagenase Santyl |
| Grt US Holding, INC. | $30.69 | 2022 | |
| Amgen INC. | $23.55 | 2025 | Krystexxa |
| Pacira Pharmaceuticals Incorporated | $15.52 | 2025 | Exparel |
| Tei Medical INC. | $13.51 | 2019 | |
| Merck Sharp & Dohme LLC | $13.49 | 2019 | |
| Advanced Oxygen Therapy INC. | $11.57 | 2023 | Topical Oxygen Chamber For Extremities |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Samera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.